Acarix AS Valuation

ACARIX Stock  SEK 0.32  0.01  3.03%   
Acarix AS seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Acarix AS from analyzing the firm fundamentals such as return on equity of -1.46, and Operating Margin of (13.75) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.32
Please note that Acarix AS's price fluctuation is out of control at this time. Calculation of the real value of Acarix AS is based on 3 months time horizon. Increasing Acarix AS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Acarix AS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Acarix Stock. However, Acarix AS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.32 Real  0.27 Hype  0.32 Naive  0.31
The real value of Acarix Stock, also known as its intrinsic value, is the underlying worth of Acarix AS Company, which is reflected in its stock price. It is based on Acarix AS's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Acarix AS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.27
Real Value
6.49
Upside
Estimating the potential upside or downside of Acarix AS helps investors to forecast how Acarix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Acarix AS more accurately as focusing exclusively on Acarix AS's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.280.320.36
Details
Hype
Prediction
LowEstimatedHigh
0.020.326.54
Details
Naive
Forecast
LowNext ValueHigh
0.010.316.53
Details

Acarix AS Total Value Analysis

Acarix AS is presently forecasted to have takeover price of 51.77 M with market capitalization of 107.15 M, debt of 239 K, and cash on hands of 15.86 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Acarix AS fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
51.77 M
107.15 M
239 K
15.86 M

Acarix AS Investor Information

The company has price-to-book (P/B) ratio of 1.63. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acarix AS recorded a loss per share of 0.31. The entity had not issued any dividends in recent years. The firm had 203:186 split on the 12th of December 2022. Based on the key indicators related to Acarix AS's liquidity, profitability, solvency, and operating efficiency, Acarix AS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

Acarix AS Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Acarix AS has an asset utilization ratio of 3.17 percent. This suggests that the Company is making kr0.0317 for each dollar of assets. An increasing asset utilization means that Acarix AS is more efficient with each dollar of assets it utilizes for everyday operations.

Acarix AS Ownership Allocation

Acarix AS holds a total of 373.33 Million outstanding shares. Acarix AS shows 10.28 percent of its outstanding shares held by insiders and 2.84 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Acarix AS Profitability Analysis

The company reported the revenue of 3.76 M. Net Loss for the year was (51.73 M) with profit before overhead, payroll, taxes, and interest of 2.82 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Acarix AS's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Acarix AS and how it compares across the competition.

About Acarix AS Valuation

The stock valuation mechanism determines Acarix AS's current worth on a weekly basis. Our valuation model uses a comparative analysis of Acarix AS. We calculate exposure to Acarix AS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Acarix AS's related companies.
Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.

8 Steps to conduct Acarix AS's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Acarix AS's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Acarix AS's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Acarix AS's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Acarix AS's revenue streams: Identify Acarix AS's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Acarix AS's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Acarix AS's growth potential: Evaluate Acarix AS's management, business model, and growth potential.
  • Determine Acarix AS's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Acarix AS's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Acarix Stock analysis

When running Acarix AS's price analysis, check to measure Acarix AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acarix AS is operating at the current time. Most of Acarix AS's value examination focuses on studying past and present price action to predict the probability of Acarix AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acarix AS's price. Additionally, you may evaluate how the addition of Acarix AS to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals